Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pfizer Launches Embrex® Vaccine Manual Inovoject®

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
New, compact in ovo device for vaccine manufacturers.

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes.

Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to the Embrex Vaccine Manufacturing Device (VMD) portfolio which already includes a range of in ovo devices used for the mass production of human influenza vaccines as well as other human and animal health egg-based vaccines.

This small, semi-automated device enables inoculation to be carried out in the laboratory setting, and so is aimed at vaccine manufacturers that require an alternative to high volume production. It could also be used for research and batch testing.

“The device is designed and produced specifically with the vaccine manufacturing environment in mind - for both human and animal health vaccines,” said Product Engineer, Joe Federowicz.

Federowicz continued, “It is only 30 inches wide, and thus can fit through ordinary laboratory doors. It is also fully enclosed so as to prevent dirt build up and other potential sources of contamination.”

According to Director, Gerardo Vera, Embrex VMI is likely to be of particular interest to vaccine manufacturers in Asia and Latin America markets.

“A typical animal health facility could probably install three to five of these machines, and each one would be used for a different vaccine,” Mr Vera said.

“The full-size Embrex Inovoject has been used by human vaccine manufacturers for many years for large scale flu vaccine production. The new Embrex VMI has the same industry-leading quality, features, functionality and reliability that customers have come to expect from the Embrex brand, which has been at the forefront of in ovo technology for 20 years,” said Mr Federowicz.

“We realized the need for an inoculation device which had the same engineering quality as other Embrex VMD products, but which could be installed in a much smaller area and was suited for smaller production runs.

“It took about a year to refine the design and bring it to market because the quality had to be superlative and up to industry standards. But I am really pleased with the result. The finish has to be seen to be believed: with no visible welds and mirror finish surfaces.”

Embrex VMI is available with the same world-class customer service and parts as offered with Pfizer Animal Health’s existing devices in the poultry business.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Researchers Find a Gap in the Brain’s Firewall Against Parkinson’s Disease
Researchers at NIH have found mouse study that identified a key player in the progression of the disorder.
Fat Cells That Amplify Nerve Signals in Response to Cold Also Affect Blood Sugar Metabolism
Researchers at UTSW have found that the protein connexin 43 forms cell-to-cell communication channels on the surface of emerging beige fat cells that amplify the signals from those few nerve fibers.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!